These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

895 related items for PubMed ID: 28238744

  • 1. Peanut Allergen Threshold Study (PATS): Novel single-dose oral food challenge study to validate eliciting doses in children with peanut allergy.
    Hourihane JO, Allen KJ, Shreffler WG, Dunngalvin G, Nordlee JA, Zurzolo GA, Dunngalvin A, Gurrin LC, Baumert JL, Taylor SL.
    J Allergy Clin Immunol; 2017 May; 139(5):1583-1590. PubMed ID: 28238744
    [Abstract] [Full Text] [Related]

  • 2. Modified oral food challenge used with sensitization biomarkers provides more real-life clinical thresholds for peanut allergy.
    Blumchen K, Beder A, Beschorner J, Ahrens F, Gruebl A, Hamelmann E, Hansen G, Heinzmann A, Nemat K, Niggemann B, Wahn U, Beyer K.
    J Allergy Clin Immunol; 2014 Aug; 134(2):390-8. PubMed ID: 24831438
    [Abstract] [Full Text] [Related]

  • 3. The diagnostic value of component-resolved diagnostics in peanut allergy in children attending a Regional Paediatric Allergology Clinic.
    van Veen LN, Heron M, Batstra M, van Haard PMM, de Groot H.
    BMC Pediatr; 2016 Jun 02; 16():74. PubMed ID: 27255511
    [Abstract] [Full Text] [Related]

  • 4. Objective eliciting doses of peanut-allergic adults and children can be combined for risk assessment purposes.
    Klemans RJ, Blom WM, van Erp FC, Masthoff LJ, Rubingh CM, van der Ent CK, Bruijnzeel-Koomen CA, Houben GF, Pasmans SG, Meijer Y, Knulst AC.
    Clin Exp Allergy; 2015 Jul 02; 45(7):1237-44. PubMed ID: 25900644
    [Abstract] [Full Text] [Related]

  • 5. The fraction of exhaled nitric oxide improves prediction of clinical allergic reaction to peanut challenge in children.
    Preece K, Bhatia R, Belcher J, Patchett K, McElduff P, Collison A, Mattes J.
    Clin Exp Allergy; 2014 Mar 02; 44(3):371-80. PubMed ID: 24345088
    [Abstract] [Full Text] [Related]

  • 6. IgE recognition patterns in peanut allergy are age dependent: perspectives of the EuroPrevall study.
    Ballmer-Weber BK, Lidholm J, Fernández-Rivas M, Seneviratne S, Hanschmann KM, Vogel L, Bures P, Fritsche P, Summers C, Knulst AC, Le TM, Reig I, Papadopoulos NG, Sinaniotis A, Belohlavkova S, Popov T, Kralimarkova T, de Blay F, Purohit A, Clausen M, Jedrzejczak-Czechowcz M, Kowalski ML, Asero R, Dubakiene R, Barreales L, Clare Mills EN, van Ree R, Vieths S.
    Allergy; 2015 Apr 02; 70(4):391-407. PubMed ID: 25620497
    [Abstract] [Full Text] [Related]

  • 7. The component-specific to total IgE ratios do not improve peanut and hazelnut allergy diagnoses.
    Grabenhenrich L, Lange L, Härtl M, Kalb B, Ziegert M, Finger A, Harandi N, Schlags R, Gappa M, Puzzo L, Stephan V, Heigele T, Büsing S, Ott H, Niggemann B, Beyer K.
    J Allergy Clin Immunol; 2016 Jun 02; 137(6):1751-1760.e8. PubMed ID: 27087317
    [Abstract] [Full Text] [Related]

  • 8. Allergen-specific oral immunotherapy for peanut allergy.
    Nurmatov U, Venderbosch I, Devereux G, Simons FE, Sheikh A.
    Cochrane Database Syst Rev; 2012 Sep 12; 2012(9):CD009014. PubMed ID: 22972130
    [Abstract] [Full Text] [Related]

  • 9. Gender, prick test size and rAra h 2 sIgE level may predict the eliciting dose in patients with peanut allergy: Evidence from the Mirabel survey.
    Elegbede CF, Papadopoulos A, Just J, Moneret-Vautrin DA, Deschildre A, Crépet A.
    Clin Exp Allergy; 2019 May 12; 49(5):677-689. PubMed ID: 30689235
    [Abstract] [Full Text] [Related]

  • 10. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK, Pelkonen AS, Mäkinen-Kiljunen S, Voutilainen H, Mäkelä MJ.
    Allergy; 2015 Oct 12; 70(10):1239-45. PubMed ID: 26095653
    [Abstract] [Full Text] [Related]

  • 11. The clinical and immunological effects of Pru p 3 sublingual immunotherapy on peach and peanut allergy in patients with systemic reactions.
    Gomez F, Bogas G, Gonzalez M, Campo P, Salas M, Diaz-Perales A, Rodriguez MJ, Prieto A, Barber D, Blanca M, Torres MJ, Mayorga C.
    Clin Exp Allergy; 2017 Mar 12; 47(3):339-350. PubMed ID: 28160513
    [Abstract] [Full Text] [Related]

  • 12. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut.
    Santos AF, Du Toit G, Douiri A, Radulovic S, Stephens A, Turcanu V, Lack G.
    J Allergy Clin Immunol; 2015 Jan 12; 135(1):179-86. PubMed ID: 25567046
    [Abstract] [Full Text] [Related]

  • 13. Influence of age on IgE response in peanut-allergic children and adolescents from the Mediterranean area.
    Garcia-Blanca A, Aranda A, Blanca-Lopez N, Perez D, Gomez F, Mayorga C, Torres MJ, Diaz-Perales A, Perkins JR, Villalba M, Blanca M, Canto G.
    Pediatr Allergy Immunol; 2015 Sep 12; 26(6):497-502. PubMed ID: 26046378
    [Abstract] [Full Text] [Related]

  • 14. Utility of specific IgE to Ara h 6 in peanut allergy diagnosis.
    Pedrosa M, Boyano-Martínez T, García-Ara C, Caballero T, Quirce S.
    Ann Allergy Asthma Immunol; 2015 Aug 12; 115(2):108-12. PubMed ID: 26073164
    [Abstract] [Full Text] [Related]

  • 15. The value of specific IgE to peanut and its component Ara h 2 in the diagnosis of peanut allergy.
    Lopes de Oliveira LC, Aderhold M, Brill M, Schulz G, Rolinck-Werninghaus C, Clare Mills EN, Niggemann B, Naspitz CK, Wahn U, Beyer K.
    J Allergy Clin Immunol Pract; 2013 Aug 12; 1(4):394-8. PubMed ID: 24565545
    [Abstract] [Full Text] [Related]

  • 16. Skin prick test responses and allergen-specific IgE levels as predictors of peanut, egg, and sesame allergy in infants.
    Peters RL, Allen KJ, Dharmage SC, Tang ML, Koplin JJ, Ponsonby AL, Lowe AJ, Hill D, Gurrin LC, HealthNuts Study.
    J Allergy Clin Immunol; 2013 Oct 12; 132(4):874-80. PubMed ID: 23891354
    [Abstract] [Full Text] [Related]

  • 17. Determination of no-observed-adverse-effect levels and eliciting doses in a representative group of peanut-sensitized children.
    Flinterman AE, Pasmans SG, Hoekstra MO, Meijer Y, van Hoffen E, Knol EF, Hefle SL, Bruijnzeel-Koomen CA, Knulst AC.
    J Allergy Clin Immunol; 2006 Feb 12; 117(2):448-54. PubMed ID: 16461147
    [Abstract] [Full Text] [Related]

  • 18. AR101 Oral Immunotherapy for Peanut Allergy.
    PALISADE Group of Clinical Investigators, Vickery BP, Vereda A, Casale TB, Beyer K, du Toit G, Hourihane JO, Jones SM, Shreffler WG, Marcantonio A, Zawadzki R, Sher L, Carr WW, Fineman S, Greos L, Rachid R, Ibáñez MD, Tilles S, Assa’ad AH, Nilsson C, Rupp N, Welch MJ, Sussman G, Chinthrajah S, Blumchen K, Sher E, Spergel JM, Leickly FE, Zielen S, Wang J, Sanders GM, Wood RA, Cheema A, Bindslev-Jensen C, Leonard S, Kachru R, Johnston DT, Hampel FC, Kim EH, Anagnostou A, Pongracic JA, Ben-Shoshan M, Sharma HP, Stillerman A, Windom HH, Yang WH, Muraro A, Zubeldia JM, Sharma V, Dorsey MJ, Chong HJ, Ohayon J, Bird JA, Carr TF, Siri D, Fernández-Rivas M, Jeong DK, Fleischer DM, Lieberman JA, Dubois AEJ, Tsoumani M, Ciaccio CE, Portnoy JM, Mansfield LE, Fritz SB, Lanser BJ, Matz J, Oude Elberink HNG, Varshney P, Dilly SG, Adelman DC, Burks AW.
    N Engl J Med; 2018 Nov 22; 379(21):1991-2001. PubMed ID: 30449234
    [Abstract] [Full Text] [Related]

  • 19. Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy.
    Vickery BP, Scurlock AM, Kulis M, Steele PH, Kamilaris J, Berglund JP, Burk C, Hiegel A, Carlisle S, Christie L, Perry TT, Pesek RD, Sheikh S, Virkud Y, Smith PB, Shamji MH, Durham SR, Jones SM, Burks AW.
    J Allergy Clin Immunol; 2014 Feb 22; 133(2):468-75. PubMed ID: 24361082
    [Abstract] [Full Text] [Related]

  • 20. Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts.
    Beyer K, Ellman-Grunther L, Järvinen KM, Wood RA, Hourihane J, Sampson HA.
    J Allergy Clin Immunol; 2003 Jul 22; 112(1):202-7. PubMed ID: 12847500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.